Purchase Order 75F40119P10697
Award Date
9/30/19
Potential Completion Date
9/29/23
Potential Value
$4.9M
Federal Agency
Food and Drug Administration
Awardee
Vitalant
Ultimate Awardee
Not listed
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This cost-plus-fixed-fee contract was awarded by the Centers for Disease Control and Prevention to Vitalant Research Institute to characterize the seroprevalence of SARS-CoV-2 antibodies in the U.S. population through May 2024. The $46.4 million contract expands Vitalant's ongoing work under the National SARS-CoV-2 Seroincidence Studies in Blood Donors contract to provide additional longitudinal data on antibody stability and reinfection risk through testing approximately 130,000 blood donors....
This federal contract was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vitalant, a nonprofit organization that provides blood products and conducts research related to transfusion medicine. The contract, titled "REDS-III" (Recipient Epidemiology and Donor Evaluation Study - III), has a ceiling value of $8,847,513.18 and a period of performance ending on December 31, 2019. The contract does not have a set-aside...
This is a $4,595,658.07 Definitive Contract awarded by the Food and Drug Administration (FDA) to Vitalant, a nonprofit organization, for the Transfusion-Transmissible Infections Monitoring System (TTIMS) Laboratory and Risk Factor Coordinating Center (LRCC) Services. The contract's primary objectives are to coordinate the collection of risk factor data, integrate data and surveillance information, evaluate and monitor risk factors, and conduct specialized testing and analysis related to HIV,...
This is a $493,905.79 delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute to The Institute For Transfusion Medicine, doing business as Vitalant Research Institute (a division of the nonprofit organization Vitalant). The order is for the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) - Phase 3 - Domestic Site and has a completion date of December 31, 2019. The contract type is Cost No...
This federal contract award, with an ID of 75N92019D00034|75N92024F00001, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the prime contractor Vitalant, a non-profit organization. The contract, valued at $2,104,121.00, is for the REDS-IV-P DOMESTIC HUBS project and does not have a set-aside designation. Vitalant Research Institute (VRI), the research arm of Vitalant, is the prime contractor. VRI has established itself as a key federal partner, providing...
This is a $5,823,074.23 firm fixed price delivery order contract awarded by the Food and Drug Administration to the non-profit organization Vitalant Research Institute (VRI) for the Transfusion-Transmissible Infections Monitoring System (TTIMS) Laboratory & Risk Factor Database Coordinating Center. The contract has no set-aside designation and was awarded on September 23, 2016, with a completion date of September 24, 2021. VRI, the prime contractor, has subcontracted with several other...
This federal contract award is for the REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2 project, awarded by the National Heart Lung and Blood Institute (NHLBI) to the prime contractor, Vitalant Research Institute (VRI), a nonprofit organization. The $4,908,528.00 cost-type delivery order contract has a completion date of March 31, 2025. VRI, the research arm of the nonprofit blood services provider Vitalant, will conduct the study in collaboration with the University of...
This is a $1,590,903.99 delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) within the Department of Health and Human Services (HHS) to the nonprofit organization Vitalant, doing business as Vitalant Research Institute (VRI). The contract is for the REDS-IV-P Domestic Hubs - Phase 1 project and does not have a set-aside designation. VRI, the research division of Vitalant, is serving as the prime contractor and is partnering with subcontractors including the...
This is a $2,206,818.78 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Vitalant (formerly Blood Systems), a nonprofit organization, to conduct clinical and epidemiological research on transfusion safety concerns as part of the REDS-IV-P Brazil Phase 1 program. The contract does not have a set-aside designation. Vitalant's research division, the Vitalant Research Institute (VRI), is the prime contractor. VRI has subcontracted with...
This is a $8,446,747.46 federal delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to Vitalant, a non-profit organization. The contract is for the REDS-IV-P - Center for Transfusion Laboratory Studies (CTLS), Phase 1, which involves necessary testing and serving as the biospecimen repository for the REDS-IV-P program. The University of Colorado-Denver is a major subcontractor on this contract, responsible...